IM
TLSIW icon

Islet Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Islet Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-163,979
Closed -$85K – 202
2021
Q4 		$85K Buy
+163,979
New +$151K ﹤0.01% 176

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Islet Management's TLSIW Position: Q1 2023 in Review

Islet Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2023, closing a stake of 65,158 shares — an estimated $4.89K sold.

Islet Management first reported a position in TLSIW in Q1 2022 and held it in 4 quarters. The position peaked at $42K in Q1 2022. 24 funds tracked by Wall St. Rank hold TLSIW as of Q1 2023.

  • Islet Management reported no remaining TriSalus Life Sciences Warrant position as of Q1 2023 after selling out during the quarter.
  • Islet Management sold 65,158 TriSalus Life Sciences Warrant shares in Q1 2023, an estimated $4.89K.
  • Islet Management first reported a position in TriSalus Life Sciences Warrant in Q1 2022 and held it in 4 quarters.
  • Islet Management's TriSalus Life Sciences Warrant position peaked at $42K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2023.

Based on Islet Management's 13F filing for Q1 2023, filed 15 May 2023.